[1. A. A. Al-Badr and G. A. E. Mostafa, Pravastatin sodium, Comprehensive Profile, Prof. Drug Subst. Exc. Rel. Meth. 39 (2014) 433-513.]Search in Google Scholar
[2. M. Farnier, Pravastatin and fenofibrate in combination (Pravafenix®) for the treatment of high-risk patients with mixed hyperlipidemia, Expert Rev. Cardiovasc. Ther. 11 (2013) 253-254; DOI: 10.1586/ erc.12.191.10.1586/erc.13.8]Search in Google Scholar
[3. S. Bauer, J. Mwinyi, A. Stoeckle, T. Gerloff and I. Roots, Quantification of pravastatin in human plasma and urine after solid phase extraction using high performance liquid chromatography with ultraviolet detection, J. Chromatogr. B 818 (2005) 257-262; DOI: 10.1016/j.jchromb.2005.01.006.10.1016/j.jchromb.2005.01.006]Search in Google Scholar
[4. T. D. Silva, M. A. Oliveira, R. B. de Oliveira and C. D. Vianna-Soares, Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin and simvastatin, J. Chromatogr. Sci. 50 (2012) 831-838; DOI: 10.1093/chromsci/bms079.10.1093/chromsci/bms079]Search in Google Scholar
[5. R. Siekmeier, W. Gross and W. März, Determination of pravastatin by high performance liquid chromatography, Int. J. Clin. Pharmacol. Ther. 38 (2000) 419-425.10.5414/CPP38419]Search in Google Scholar
[6. H. Vlčková, M. Rabatinová, A. Mikšová, G. Kolouchová, S. Mičuda, P. Solich and L. Nováková, Determination of pravastatin and pravastatin lactone in rat plasma and urine using UHPLC-MS/ MS and microextraction by packed sorbent, Talanta 90 (2012) 22-29; DOI: 10.1016/j.talanta.2011.12.043.10.1016/j.talanta.2011.12.043]Search in Google Scholar
[7. Z. Zhu and L. Neirinck, High-performance liquid chromatography coupled with negative ion tandem mass spectrometry for determination of pravastatin in human plasma, J. Chromatogr. B 783 (2003) 133-140; DOI: 10.1016/S1570-0232(02)00526-3.10.1016/S1570-0232(02)00526-3]Search in Google Scholar
[8. D. Mulvana, M. Jemal and S. C. Pulver, Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS, J. Pharm. Biomed. Anal. 23 (2000) 851-866, DOI: 10.1016/S0731-7085(00)00372-1.10.1016/S0731-7085(00)00372-1]Search in Google Scholar
[9. K. Kawabata, N. Matsushima and K. Sasahara, An automated method for the simultaneous determination of pravastatin and its main metabolite in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry, Biomed. Chromatogr. 12 (1998) 271-275; DOI: 10.1002/(SICI)1099-0801(199809/10)12:5 < 27.]Search in Google Scholar
[10. B. Nigović, Electrochemical properties and square-wave voltammetric determination of pravastatin, Anal. Bioanal. Chem. 384 (2006) 431-437.10.1007/s00216-005-0188-116341509]Search in Google Scholar
[11. United States Pharmacopoeia 30, USP Convention Inc., Rockville, 2007.]Search in Google Scholar
[12. British Pharmacopoeia 2004, The Stationary Office, London 2004, p. 639.]Search in Google Scholar
[13. R. J. Straka, R. T. Burkhardt and J. E. Fisher, Determination of fenofibric acid concentrations by HPLC after anion exchange solid-phase extraction from human serum, Ther. Drug Monit. 29 (2007) 197-202; DO I: 10.1097/ftd.0b013e318030860a.10.1097/ftd.0b013e318030860a17417074]Search in Google Scholar
[14. A. A. Kadav and D. N. Vora, Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets, J. Pharm. Biomed. Anal. 48 (2008) 120-126; DOI: 10.1016/j.jpba.2008.05.018.10.1016/j.jpba.2008.05.01818583084]Search in Google Scholar
[15. D. Bhavesh, S. Shah and Shivprakash, Determination of fenofibric acid in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry: application to a bioequivalence study, Biomed. Chromatogr. 23 (2009) 922-928, DOI: 10.1002/bmc.1203.10.1002/bmc.120319353730]Search in Google Scholar
[16. C. Yardimci and N. Ozaltin, Electrochemical studies and square-wave voltammetric determination of fenofibrate in pharmaceutical formulations, Anal. Bioanal. Chem. 378 (2004) 495-498; DOI: 10.1007/s00216-003-2246-x.10.1007/s00216-003-2246-x14564444]Search in Google Scholar
[17. M. A. Korany, I. I. Hewala and K. M. Abdel-Hay, Determination of etofibrate, fenofibrate, and atorvastatin in pharmaceutical preparations and plasma using differential pulse polarographic and square wave voltammetric techniques, J AOAC Int. 91 (2008) 1051-1058.10.1093/jaoac/91.5.1051]Search in Google Scholar
[18. P. D. Anumolu, N. S. Bhavani, P. S. Babu and C. Sburahmanyam, A validated spectral discriminating derivative spectrophotometric method for simultaneous quantification of atorvastatin calcium and fenofibrate combination in tablets, Orint. J. Chem. 29 (2013) 1605-1610, DOI: 10.13005/ ojc/290444.10.13005/ojc/290444]Search in Google Scholar
[19. A. Patel, C. Macwana, V. Pamar and S. Patel, Simultaneous determination of atorvastatin calcium, ezetimibe, and fenofibrate in tablet formulation by HPLC, JAOAC 95 (2012) 419-423.10.5740/jaoacint.1-09522649929]Search in Google Scholar
[20. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1), ICH Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.]Search in Google Scholar
[21. FDA Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER ), Center for Biologics Evaluation and Research (CBER), Rockville (MD) 2001.]Search in Google Scholar
[22. J. N. Miller and J. C. Miller, Statistics and Chemometrics for Analytical Chemistry, 2nd ed., Pearson Education Limited, Harlow 2005. ]Search in Google Scholar